We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+11.75%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$65.7B
AUM Growth
+$6.62B
Cap. Flow
+$648M
Cap. Flow %
0.99%
Top 10 Hldgs %
27.2%
Holding
2,939
New
828
Increased
695
Reduced
744
Closed
553

Top Sells

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$400M
2
STZ icon
Constellation Brands
STZ
+$345M
3
META icon
Meta Platforms (Facebook)
META
+$286M
4
KVUE icon
Kenvue
KVUE
+$277M
5
ABBV icon
AbbVie
ABBV
+$258M

Sector Composition

Rank Sector Weight
1 Technology 16.4%
2 Healthcare 13.22%
3 Consumer Discretionary 12.71%
4 Financials 7.66%
5 Communication Services 7.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
URG
1351
Ur-Energy
URG
$485M
$1.96M ﹤0.01%
+1,227,345
New +$2.04M
MOMO
1352
Hello Group
MOMO
$867M
$1.96M ﹤0.01%
315,700
+87,341
+38% +$554K
PLRX icon
1353
Pliant Therapeutics
PLRX
$66.9M
$1.95M ﹤0.01%
+130,935
New +$2.16M
ROK icon
1354
Rockwell Automation
ROK
$52.6B
$1.95M ﹤0.01%
6,687
-155,466
-96% -$44.8M
FLR icon
1355
Fluor
FLR
$6.89B
$1.94M ﹤0.01%
45,997
-309,141
-87% -$11.9M
ERII icon
1356
Energy Recovery
ERII
$435M
$1.94M ﹤0.01%
+122,799
New +$1.95M
WVE icon
1357
Wave Life Sciences
WVE
$1.14B
$1.93M ﹤0.01%
313,405
-186,804
-37% -$935K
MGX icon
1358
Metagenomi Therapeutics
MGX
$45.2M
$1.93M ﹤0.01%
+183,027
New +$2.1M
NWG icon
1359
NatWest
NWG
$70.8B
$1.93M ﹤0.01%
283,530
-80,909
-22% -$480K
WLY icon
1360
John Wiley & Sons Class A
WLY
$2.72B
$1.92M ﹤0.01%
50,418
-309,935
-86% -$10.6M
BB icon
1361
BlackBerry
BB
$4.7B
$1.92M ﹤0.01%
+696,523
New +$2.04M
AEL
1362
DELISTED
American Equity Investment Life Holding Company
AEL
$1.92M ﹤0.01%
34,188
+18,788
+122% +$1.04M
APEI icon
1363
American Public Education
APEI
$920M
$1.92M ﹤0.01%
134,936
+62,927
+87% +$740K
CAMT icon
1364
Camtek
CAMT
$6.53B
$1.91M ﹤0.01%
+22,829
New +$1.79M
CECO icon
1365
Ceco Environmental
CECO
$3.95B
$1.91M ﹤0.01%
82,860
+39,616
+92% +$816K
CMG icon
1366
CALL
Chipotle Mexican Grill
CMG
$42.7B
$1.91M ﹤0.01%
+30,000
New +$1.53M
ACT icon
1367
Enact Holdings
ACT
$6.68B
$1.9M ﹤0.01%
61,046
+41,266
+209% +$1.17M
CVEO icon
1368
Civeo
CVEO
$373M
$1.9M ﹤0.01%
70,630
+46,979
+199% +$1.09M
XLY icon
1369
PUT
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$21.9B
$1.89M ﹤0.01%
21,200
-400,000
-95% -$35.6M
CRBU icon
1370
Caribou Biosciences
CRBU
$149M
$1.89M ﹤0.01%
368,257
+310,527
+538% +$1.91M
ADVM
1371
DELISTED
Adverum Biotechnologies
ADVM
$1.89M ﹤0.01%
+133,851
New +$2.04M
UGP icon
1372
Ultrapar
UGP
$6.77B
$1.89M ﹤0.01%
+330,513
New +$1.91M
PPYAW
1373
CALL
DELISTED
Papaya Growth Opportunity Corp. I Warrant
PPYAW
$1.88M ﹤0.01%
169,211
-70,000
-29% -$3.51K
AKBA icon
1374
Akebia Therapeutics
AKBA
$335M
$1.87M ﹤0.01%
+1,023,275
New +$1.64M
SQSP
1375
DELISTED
Squarespace, Inc.
SQSP
$1.87M ﹤0.01%
51,367
-10,368
-17% -$337K

Similar funds

Marshall Wace's Q1 2024 Portfolio in Review

As of Q1 2024, Marshall Wace held 2,939 positions worth $65.7B, up 11% from $59B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Marshall Wace's Q1 2024 filing shows 828 new, 695 increased, 744 reduced and 553 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 900,000 shares worth $433M. The largest sale was Walmart Inc, an estimated $400M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Marshall Wace's largest Q1 2024 buy was Vanguard S&P 500 ETF: 900,000 shares worth $433M.
  • Marshall Wace added most to Goldman Sachs in Q1 2024, an estimated $374M increase.
  • Marshall Wace's biggest Q1 2024 reduction was Walmart Inc, cutting an estimated $400M.
  • Marshall Wace fully exited Celsius Holdings in Q1 2024, selling an estimated $143M.
  • Marshall Wace's ten largest holdings make up 27% of its $65.7B portfolio in Q1 2024.
  • Marshall Wace opened 828 new positions and closed 553 in Q1 2024.
  • Marshall Wace's portfolio value rose 11% quarter-over-quarter to $65.7B.

Based on Marshall Wace's 13F filing for Q1 2024, filed 15 May 2024.